GDF‐15 was associated with all‐cause mortality in the total cohort, whereas in the subgroup analysis, interestingly, association with outcome remained significant only for solid tumours but not for myelodysplastic or myeloproliferative disease, indicating different disease‐related mechanisms of the protein. The gene discussed is GDF15; the disease is myeloproliferative disorder.